Financial Summary
Annual report financial report (PDF) | Audited financials (PDF)
For the Population Council, 2010 was a year of successful program implementation supported by strong fundraising efforts.
The Council was awarded $47 million in new grants, an increase of $8 million over 2009. Conditional funding commitments increased from $20 million in 2009 to almost $51 million in 2010. These conditional funding commitments will be recorded as revenue in 2011 and subsequent years as programs are carried out. The pie charts below provide additional information on the sources and uses of our funding.
Program spending totaled $77 million, which represents 86 percent of our 2010 total operating expenses. This means that the Council invests 86 cents of every dollar in research and programmatic activities.
The Council introduced a new accounting software system in its international offices. We anticipate that the new software will increase efficiency, enhance timely reporting of financial activities, and further reduce administrative costs.
In February 2010, the Council signed a licensing agreement with Watson Pharmaceuticals, Inc., granting them the North American rights to the contraceptive vaginal ring. This agreement led to a 48 percent increase in the Council's royalty income for 2010.
Board-designated unrestricted funds provide the Council with a stable financial base from which to respond to requests for assistance and collaboration. In 2010, the Council's investments, including the John D. Rockefeller 3rd Memorial Fund, enjoyed a healthy return despite the stock market declines in 2008 and 2009.
We closely monitor the Council's financial condition and remain committed to the fiscal discipline necessary to maintain our record of accomplishments.
